Lineage Cell Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LCTX and other ETFs, options, and stocks.About LCTX
Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery.
LCTX Key Statistics
Stock Snapshot
Lineage Cell Therapeutics(LCTX) stock is priced at $1.10, giving the company a market capitalization of 279.46M. It carries a P/E multiple of -5.97.
Lineage Cell Therapeutics(LCTX) stock opened on 2026-09-01 at $1.13. The price climbed to — and dipped to —.
Lineage Cell Therapeutics(LCTX) shares are trading with a volume of 0, against a daily average of 884.29K.
In the last year, Lineage Cell Therapeutics(LCTX) shares hit a 52-week high of $2.09 and a 52-week low of $1.00.
In the last year, Lineage Cell Therapeutics(LCTX) shares hit a 52-week high of $2.09 and a 52-week low of $1.00.
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.